Broadwood Partners, L.P. Staar Surgical CO (STAA) insider trading activity

Broadwood Partners, L.P. is > 10% Shareholder of STAAR SURGICAL CO. Currently has a direct ownership of 13.5 Million shares of STAA, which is worth approximately $230 Million. The most recent transaction as insider was on Apr 10, 2025, when has been sold 900 shares (Common Stock) at a price of $15.18 per share, resulting in proceeds of $13,662. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.5M

12.84% 3M change

25.55% 12M change

Total Value Held $230 Million

BROADWOOD PARTNERS, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 10 2025	BUY Open market or private purchase	$13,662 $15.18 p/Share	900 Added 0.01%	13,519,491 Common Stock
Apr 09 2025	BUY Open market or private purchase	$123,656 $15.08 p/Share	8,200 Added 0.06%	13,518,591 Common Stock
Apr 08 2025	BUY Open market or private purchase	$2,782,343 $15.62 p/Share	178,127 Added 1.3%	13,510,391 Common Stock
Apr 07 2025	BUY Open market or private purchase	$2,178,492 $15.78 p/Share	138,054 Added 1.02%	13,332,264 Common Stock
Apr 04 2025	BUY Open market or private purchase	$8,051,669 $16.18 p/Share	497,631 Added 3.63%	13,194,210 Common Stock
Apr 03 2025	BUY Open market or private purchase	$3,555,808 $16.97 p/Share	209,535 Added 1.62%	12,696,579 Common Stock
Apr 02 2025	BUY Open market or private purchase	$553,925 $17.43 p/Share	31,780 Added 0.25%	12,487,044 Common Stock
Mar 31 2025	BUY Open market or private purchase	$387,419 $17.46 p/Share	22,189 Added 0.18%	12,455,264 Common Stock
Mar 28 2025	BUY Open market or private purchase	$142,048 $17.47 p/Share	8,131 Added 0.07%	12,433,075 Common Stock
Mar 27 2025	BUY Open market or private purchase	$63,277 $17.48 p/Share	3,620 Added 0.03%	12,424,944 Common Stock
Mar 26 2025	BUY Open market or private purchase	$1,778,577 $17.5 p/Share	101,633 Added 0.81%	12,421,324 Common Stock
Mar 25 2025	BUY Open market or private purchase	$598,122 $17.44 p/Share	34,296 Added 0.28%	12,319,691 Common Stock
Mar 21 2025	BUY Open market or private purchase	$1,816,575 $17.74 p/Share	102,400 Added 0.83%	12,285,395 Common Stock
Mar 20 2025	BUY Open market or private purchase	$1,952,611 $17.96 p/Share	108,720 Added 0.88%	12,182,995 Common Stock
Mar 18 2025	BUY Open market or private purchase	$1,638,051 $17.59 p/Share	93,124 Added 0.77%	12,074,275 Common Stock
Mar 04 2025	BUY Open market or private purchase	$484,145 $17.32 p/Share	27,953 Added 0.23%	11,981,151 Common Stock
Mar 03 2025	BUY Open market or private purchase	$4,241,551 $17.0 p/Share	249,503 Added 2.04%	11,953,198 Common Stock
Feb 28 2025	BUY Open market or private purchase	$2,745,572 $17.72 p/Share	154,942 Added 1.31%	11,703,695 Common Stock
Feb 27 2025	BUY Open market or private purchase	$4,403,185 $16.98 p/Share	259,316 Added 2.2%	11,548,753 Common Stock
Feb 14 2025	BUY Open market or private purchase	$565,880 $15.49 p/Share	36,532 Added 0.32%	11,289,437 Common Stock
Feb 13 2025	BUY Open market or private purchase	$1,826,066 $15.84 p/Share	115,282 Added 1.01%	11,252,905 Common Stock
Feb 12 2025	BUY Open market or private purchase	$3,865,682 $14.89 p/Share	259,616 Added 2.28%	11,137,623 Common Stock
Jan 16 2025	BUY Open market or private purchase	$176,751 $21.5 p/Share	8,221 Added 0.08%	10,878,007 Common Stock
Jan 14 2025	BUY Open market or private purchase	$453,986 $21.46 p/Share	21,155 Added 0.19%	10,869,786 Common Stock
Dec 18 2024	BUY Open market or private purchase	$559,590 $24.33 p/Share	23,000 Added 0.21%	10,848,631 Common Stock

Also insider at

LCTX

Lineage Cell Therapeutics, Inc. Healthcare

Director

CMRO

COMARCO INC

> 10% Shareholder

OCX

Oncocyte Corp Healthcare

> 10% Shareholder

BPL